An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Roche

Status: Completed

Conditions: Hepatitis B, Chronic

Study type: Observational

Funder types: Industry

Identifiers

NCT01011738

MV22009

Details and patient eligibility

About

This observational, non-interventional cohort study will evaluate predictors of response in patients with chronic hepatitis B receiving standard of care Pegasys therapy. Efficacy and safety parameters will also be evaluated. Patients included in the study will be followed for the duration of their treatment and for up to 3 years thereafter.

Enrollment: 1,842 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• adult patient, >/= 18 years of age
• chronic hepatitis B
• treatment with peginterferon alfa-2A

Exclusion criteria

• coinfection with HAV, HCV and HIV

Trial design

1,842 participants in 1 patient group

Cohort